封面
市場調查報告書
商品編碼
1418519

單細胞基因組定序市場報告:2030 年趨勢、預測與競爭分析

Single-Cell Genome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

單細胞基因組定序趨勢與預測

預計 2024 年至 2030 年,全球單細胞基因組定序市場將以 14.6% 的複合年成長率成長。該市場的主要促進因素包括癌症、糖尿病和關節炎等慢性疾病的盛行率不斷上升、先進技術和現代合作研究以及老年人口的增加。全球單細胞基因組定序市場的未來看起來充滿希望,循環細胞、細胞分化/重編程、基因組變異和亞群表徵市場存在機會。

單細胞基因組定序市場洞察

Lucintel 預計,由於採用尖端設備和解決方案,設備在預測期內仍將是最大的細分市場。

由於循環性腫瘤細胞的使用不斷增加,循環細胞仍然是市場中最大的部分。

由於癌症和其他慢性病盛行率不斷上升,北美在預測期內可能仍然是最大的地區。

常問問題

Q1.市場成長預測如何?

A1. 2024年至2030年,全球單細胞基因組定序市場預計將以14.6%的複合年成長率成長。

Q2.影響市場成長的主要促進因素有哪些?

A2. 這個市場的主要促進因素是癌症、糖尿病和關節炎等慢性疾病的盛行率不斷上升、先進技術和現代協作研究以及老年人口數量的增加。

Q3.市場的主要細分市場有哪些?

A3. 單細胞基因組定序市場的未來看起來充滿希望,在循環細胞、細胞分化/重編程、基因組變異和亞群表徵市場方面存在著機會。

Q4.市場上主要企業有哪些?

A4.主要的單細胞基因組定序公司如下。

  • Bio-Rad Laboratories
  • 10X Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen

Q5.未來最大的細分市場是什麼?

A5.Lucintel 預計,由於採用尖端設備和解決方案,設備在預測期內仍將是其最大的細分市場。

Q6. 未來五年預計哪個地區將成為最大的市場?

A6. 由於癌症和其他慢性病盛行率不斷上升,預計北美在預測期內仍將是最大的地區。

Q7. 可以客製化報告嗎?

A7. 是的,Lucintel 提供 10% 的客製化服務,無需額外費用。

目錄

第1章執行摘要

第2章全球單細胞基因組定序市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球單細胞基因組定序市場趨勢(2018-2023)與預測(2024-2030)
  • 按產品類型分類的全球單細胞基因組定序市場
    • 裝置
    • 試劑
  • 按工作流程分類的全球單細胞基因組定序市場
    • 基因組分析
    • 單細胞分離
    • 樣品製備
  • 全球單細胞基因組定序市場(按應用)
    • 循環細胞
    • 細胞分化/重編程
    • 基因組變異
    • 亞群的表徵
    • 其他
  • 按最終用途分類的全球單細胞基因組定序市場
    • 學術研究所
    • 生物技術和生物製藥公司
    • 診所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球單細胞基因組定序市場(按地區)
  • 北美單細胞基因組定序市場
  • 歐洲單細胞基因組定序市場
  • 亞太地區單細胞基因體定序市場
  • 其他地區的單細胞基因組定序市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球單細胞基因組定序市場成長機會
    • 按工作流程分類的全球單細胞基因組定序市場成長機會
    • 全球單細胞基因組定序市場成長機會(依應用)
    • 全球單細胞基因組定序市場成長機會(依最終用途)
    • 全球單細胞基因組定序市場成長機會(按地區)
  • 全球單細胞基因組定序市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球單細胞基因組定序市場產能擴張
    • 全球單細胞基因組定序市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Bio-Rad Laboratories
  • 10x Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • QIAGEN
簡介目錄

Single-Cell Genome Sequencing Trends and Forecast

The future of the global single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets. The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Single-Cell Genome Sequencing by Segment

The study includes a forecast for the global single-cell genome sequencing by product type, workflow, application, end use, and region.

Single-Cell Genome Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Reagents

Single-Cell Genome Sequencing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Genomic Analysis
  • Single Cell Isolation
  • Sample Preparation

Single-Cell Genome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Circulating Cells
  • Cell Differentiation/Reprogramming
  • Genomic Variation
  • Subpopulation Characterization
  • Others

Single-Cell Genome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Laboratories
  • Biotechnology & Biopharmaceutical Companies
  • Clinics
  • Others

Single-Cell Genome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Single-Cell Genome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-cell genome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-cell genome sequencing companies profiled in this report include-

  • Bio-Rad Laboratories
  • 10X Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen

Single-Cell Genome Sequencing Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.

Within this market, circulating cells will remain the largest segment due to growing utilization of circulating tumor cells.

North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.

Features of the Global Single-Cell Genome Sequencing Market

Market Size Estimates: Single-cell genome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Single-cell genome sequencing market size by various segments, such as by product type, workflow, application, end use, and region in terms of value ($B).

Regional Analysis: Single-cell genome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, workflow, application, end use, and regions for the single-cell genome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-cell genome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for single-cell genome sequencing market?

Answer: The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the single-cell genome sequencing market?

Answer: The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.

Q3. What are the major segments for single-cell genome sequencing market?

Answer: The future of the single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets.

Q4. Who are the key single-cell genome sequencing market companies?

Answer: Some of the key single-cell genome sequencing companies are as follows.

  • Bio-Rad Laboratories
  • 10X Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen

Q5. Which single-cell genome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.

Q6. In single-cell genome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the single-cell genome sequencing market by product type (instruments and reagents), workflow (genomic analysis, single cell isolation, and sample preparation), application (circulating cells, cell differentiation/reprogramming, genomic variation, subpopulation characterization, and others), end use (academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Single-Cell Genome Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Single-Cell Genome Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Single-Cell Genome Sequencing Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Reagents
  • 3.4: Global Single-Cell Genome Sequencing Market by Workflow
    • 3.4.1: Genomic Analysis
    • 3.4.2: Single Cell Isolation
    • 3.4.3: Sample Preparation
  • 3.5: Global Single-Cell Genome Sequencing Market by Application
    • 3.5.1: Circulating Cells
    • 3.5.2: Cell Differentiation/Reprogramming
    • 3.5.3: Genomic Variation
    • 3.5.4: Subpopulation Characterization
    • 3.5.5: Others
  • 3.6: Global Single-Cell Genome Sequencing Market by End Use
    • 3.6.1: Academic & Research Laboratories
    • 3.6.2: Biotechnology & Biopharmaceutical Companies
    • 3.6.3: Clinics
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Single-Cell Genome Sequencing Market by Region
  • 4.2: North American Single-Cell Genome Sequencing Market
    • 4.2.2: North American Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others
  • 4.3: European Single-Cell Genome Sequencing Market
    • 4.3.1: European Single-Cell Genome Sequencing Market by Product Type: Instruments and Reagents
    • 4.3.2: European Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others
  • 4.4: APAC Single-Cell Genome Sequencing Market
    • 4.4.1: APAC Single-Cell Genome Sequencing Market by Product Type: Instruments and Reagents
    • 4.4.2: APAC Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others
  • 4.5: ROW Single-Cell Genome Sequencing Market
    • 4.5.1: ROW Single-Cell Genome Sequencing Market by Product Type: Instruments and Reagents
    • 4.5.2: ROW Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Workflow
    • 6.1.3: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Region
  • 6.2: Emerging Trends in the Global Single-Cell Genome Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Single-Cell Genome Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Single-Cell Genome Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Rad Laboratories
  • 7.2: 10x Genomics
  • 7.3: Novogene
  • 7.4: Fluidigm
  • 7.5: F. Hoffmann-La-Roche
  • 7.6: Illumina
  • 7.7: Oxford Nanopore Technologies
  • 7.8: Pacific Biosciences
  • 7.9: Thermo Fisher Scientific
  • 7.10: QIAGEN